Our chief medical officer, Professor Jonathan Benger, explains the crucial role the HST programme plays in encouraging ...
As set out in the NHS Commercial Framework for New Medicines, a commercial access agreement (CAA) is a complex confidential agreement and is agreed at NHS England’s discretion. A CAA proposal can only ...